Nanoengineered Therapeutics for Lung Cancer
Idioma: inglés
Editorial: Elsevier Science, 2026
- Tapa blanda
- Nuevo
Librería: moluna, Greven, Alemaniamoluna
Vendedor de IberLibro desde 9 de julio de 2020
Condición: Nuevo
EUR 177,23
Cantidad disponible: 1 disponible
Añadir al carritoDescripción del artículo del vendedor
Provides a thorough examination of the design, synthesis, and application aspects of nanodrug delivery systemsIntroduces groundbreaking and advanced methodologies for diagnosing and treating lung cancerHighlights how strategic desi.
N° de ref. del artículo 2680206489
- Título
- Nanoengineered Therapeutics for Lung Cancer
- Editorial
- Elsevier Science
- Año de publicación
- 2026
- Estado
- New
- Encuadernación
- Encuadernación de tapa blanda
- Idioma
- inglés
- ISBN 10
- 0443445850
- ISBN 13
- 9780443445859
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at the University School of Pharmaceutical Sciences, Rayat Bahra University, Sahauran, India. His research interests include nano-formulation, cancer biology, and neuroscience, alongside digital and computational approaches such as machine learning, artificial intelligence, big data analytics, blockchain, and the Internet of Things. He has contributed academic books, book chapters, and review articles in pharmaceutical sciences and healthcare technology, with a focus on interdisciplinary approaches that integrate pharmaceutical research with emerging digital technologies.
Meenakshi Dhanawat is Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, India. Her research spans medicinal chemistry, synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction, with a particular focus on central nervous system drug delivery. Dr. Dhanawat completed her M.S. (Pharm.) from the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, where her research project focused on glycosyl amino acids. She obtained her Ph.D. from the Indian Institute of Technology (IIT-BHU), Varanasi, India. She was a recipient of the Travelship Award in the DDD Section of AAPS 2010, held in California, USA. She has also received international travel grants from the Department of Biotechnology (DBT) and Department of Science and Technology (DST), Government of India, to participate in international scientific conferences in California, USA, and Munich, Germany, respectively. She has received several other fellowships and awards, including the prestigious Rajiv Gandhi National Fellowship.
Shikha Baghel Chauhan is Associate Professor in the Department of Industrial Pharmacy at Amity Institute of Pharmacy, Amity University, Noida, India. She has extensive experience spanning academia and the pharmaceutical sector. Her research interests include novel drug delivery systems, transdermal drug delivery, nanocarrier-based formulations, and herbal drug development. In addition to her teaching and research activities, Dr. Chauhan is engaged in scientific publishing and academic outreach, including educational initiatives that support pharmacy education and professional development. She has contributed to the pharmaceutical sciences literature through scholarly publications, books, book chapters, and intellectual property development. Her work focuses on advancing formulation science and drug delivery approaches to address contemporary healthcare challenges.
Dr. Indu Singh is currently serving as an Assistant Professor at the Centre of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh. Previously, she worked as an Assistant Professor in the Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar Central University, Lucknow.
She has over nine years of post-PhD teaching experience and holds a Bachelor of Pharmacy (B. Pharm.), Master of Pharmacy (M. Pharm.), and Doctor of Philosophy (Ph.D.) in Pharmaceutics. She completed her Ph.D. at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, under the Government of India, in the area of Nanomedicines specifically on bioconjugated nanotherapeutics for tumor targeting.
A gold medalist in both her B. Pharm. and M. Pharm. programs, Dr. Singh was awarded the GATE and GPAT scholarship by the Ministry of Human Resource Development (MHRD) for her M. Pharm. and the Research Fellowship from the Ministry of Chemicals and Fertilizers, Government of India for her Ph.D. studies. She is a registered pharmacist with the Pharmacy Council of India through the Uttar Pradesh Pharmacy Council, Lucknow.
In 2015, she qualified the Women Scientist-C (WOS-C) examination (KIRAN-IPR) conducted by the Department of Science and Technology (DST), New Delhi. She also received the Young Scientist International Travel Grant from the Council of Scientific and Industrial Research (CSIR), India, to attend the 6th International Conference on Nanomaterials-Research & Application (NANOCON-2014) held in Brno, Czech Republic (EU).
Dr. Singh has received numerous awards for her oral and poster presentations at various national and international conferences. She has published over 70 research papers in reputed international journals with high impact factors, authored 20 book chapters, and written four Scopus-indexed books. Additionally, she has filed four patents, with one patent already granted to her credit. She was the invited speaker for IBRO-APRC Associate School in November 2022.Dr. Niraj Kumar Jha is an Assistant Professor of Biotechnology at Galgotias University, India, with prior research affiliations at the Centre for Research Impact & Outcome (CRIO), Chitkara University, and Sharda University. His research portfolio encompasses over 200 peer-reviewed articles and scholarly reviews, along with an edited volume published by Springer, reflecting sustained contributions to biomedical research and translational science. According to Scopus metrics, Dr. Jha’s publications have garnered more than 10,000 citations, with an H-index exceeding 50, underscoring the broad impact and visibility of his work within the global scientific community. He is an elected Member of the Royal Society of Biology (MRSB), London, and has been recognized among the World’s Top 2% Scientists in rankings compiled by Elsevier in collaboration with Stanford University. Dr. Jha actively contributes to scientific publishing and peer review as an associate editor for the Journal of Alzheimer’s Disease (IOS Press) and IET Nanobiotechnology (Wiley) and serves on the editorial boards of several international journals, including Scientific Reports. His research is centered on elucidating the molecular and cellular mechanisms underlying complex diseases such as neurodegenerative disorders, cancer, and cardiovascular pathologies. His work particularly emphasizes the modulation of key signaling pathways and explores the therapeutic potential of natural products, phytochemicals, and synthetic small molecules in disease intervention.
“Acerca de” puede pertenecer a otra edición de este título.
moluna
Greven, Alemania
Vendedor de IberLibro desde 9 de julio de 2020
Tarifas de envío de Alemania a Estados Unidos de America
| Artículo | De 13 a 40 días hábiles | De 13 a 40 días hábiles |
|---|---|---|
| Primer artículo | EUR 48,99 | EUR 48,99 |
Métodos de pago
- Cheque
- Giro bancario
- PayPal
Descripción de la tienda
Online Handel nur mit Neubüchern
Información empresarial del vendedor
Moluna GmbH
Engberdingdamm 27
Greven, Alemania 48268
Condiciones de venta
Aviso legal
Reconocimiento legal del oferente:
Moluna GmbH
Representadas por el gerente Helge Blischke
Engberdingdamm 27
48268 Greven
Alemania
Teléfono: 02571/5698933
Fax: 02571/5698930
E-Mail: abe@moluna.de
Identificación tributaria del impuesto a las ganancias: DE296281834
inscripto en el Registro Público de Comercio del Tribunal de Primera Instancia Steinfurt
Número HRB de Registro en el Registro Público de Comercio 10553
Somos miembros de la iniciativa « FairCommerce » desde 24.07.2015.
Para más información, consulte: www.haendlerbund.de/faircommerce.
Derecho al desistimiento
Si es un consumidor, puede rescindir el contrato de acuerdo con lo siguiente. Por consumidor se entiende cualquier persona física que actúe con fines ajenos a su actividad comercial, empresarial, oficio o profesión.
Información sobre el derecho de desistimiento
Derecho legal de desistimiento
Tiene derecho a rescindir este contrato en un plazo de 14 días sin dar ningún motivo.
El periodo de desistimiento vencerá a los 14 días desde que usted, o un tercero que no sea el transportista e indicado por usted, adquiera la posesión física del último bien o del último lote o pieza.
Para ejercer el derecho de desistimiento, complete de forma electrónica y envíe una declaración clara en nuestro sitio web, desde "Mis compras" en "Mi cuenta". Le enviaremos sin demora un acuse de recibo de dicho desistimiento a través de un soporte duradero (por ejemplo, por correo electrónico).
Para cumplir con el plazo de desistimiento, basta con que envíe su comunicación relativa al ejercicio del derecho de desistimiento antes de que venza el periodo de desistimiento.
Efectos del desistimiento
Si rescinde este contrato, le reembolsaremos todos los pagos que hayamos recibido de usted, incluidos los gastos de envío (excepto los gastos adicionales que surjan si elige un tipo de envío que no sea el tipo de envío estándar más económico que ofrecemos).
Podemos hacer una deducción del reembolso por la pérdida de valor de cualquier bien suministrado, si la pérdida es el resultado de una manipulación innecesaria por su parte.
Efectuaremos el reembolso sin demoras indebidas y, a más tardar, 14 días después de que se nos informe de su decisión de rescindir este contrato.
Efectuaremos el reembolso utilizando el mismo medio de pago que utilizó para la transacción inicial, a menos que haya acordado expresamente lo contrario; en cualquier caso, no incurrirá en ningún cargo como resultado de dicho reembolso.
Podremos retener el reembolso hasta que hayamos recibido los bienes o hasta que nos haya presentado una prueba de que los ha devuelto, lo que ocurra primero.
Deberá devolver los bienes o entregarlos a moluna, Greven, Germany, sin demoras indebidas y, en cualquier caso, en un plazo máximo de 14 días a partir del día en que nos comunique su desistimiento del presente contrato. El plazo se cumple si devuelve la mercancía antes de que venza el periodo de 14 días. Tendrá que asumir los gastos directos de devolución de los bienes. Usted solo es responsable de la disminución del valor de los bienes como resultado de una manipulación distinta a la necesaria para establecer la naturaleza, las características y el funcionamiento de los bienes.
Excepciones al derecho de desistimiento
El derecho de desistimiento no se aplica a lo siguiente:
- La entrega de periódicos, diarios o revistas, con la excepción de los contratos de suscripción; y
- El suministro de contenido digital que no se proporcione en un soporte tangible (por ejemplo, en un CD o DVD) si, al hacer el pedido, aceptó que podíamos empezar a entregarlo y que no podría desistir una vez iniciada la entrega.